( July 13, 2026, 16:34 GMT | Official Statement) -- MLex Summary: Edwards Lifesciences Corp. and Genesis Medtech Group will pay $10 million and $2 million, respectively, in civil penalties after failing to comply with the Hart-Scott-Rodino Act, according to a complaint and proposed final judgment filed by the US Department of Justice. Edwards worked to acquire JC Medical from Genesis alongside its pursuit of JenaValve Technologies, and allegedly specifically sought to avoid triggering Hart-Scott-Rodino Act reporting thresholds with the deal. Edwards ultimately acquired JC Medical for $115 million, just below the $119.5 million threshold, but also made an investment in Genesis of $10-$35 million to close the gap in valuation.See attached files....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.